A Multicenter Prospective Study of Quality of Life in Adult Scoliosis
ASLS
2 other identifiers
interventional
286
2 countries
9
Brief Summary
This is a multicenter study evaluating the effectiveness of nonoperative and operative treatments. The investigators wish to identify important clinical and radiographic determinants of outcomes in the management of adults with symptomatic lumbar scoliosis (ASLS). Note: Enrollment was complete July 2014. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) funding ended 2/28/17. We continue to follow enrolled subjects while we seek additional funding to follow all subjects through 8 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2010
Longer than P75 for not_applicable
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2009
CompletedFirst Posted
Study publicly available on registry
March 3, 2009
CompletedStudy Start
First participant enrolled
April 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2017
CompletedResults Posted
Study results publicly available
September 14, 2021
CompletedSeptember 14, 2021
August 1, 2021
6.9 years
March 2, 2009
June 2, 2021
September 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Scoliosis Research Society Quality of Life Questionnaire (SRS QOL) Subscore
Change was calculated as the SRS QOL Subscore value at 2-year minus the value at Baseline for Randomized Cohort (Intent-to-Treat analysis). SRS QOL Subscore value range is 1 to 5, where 5 is the best score and 1 is the worst score possible.
Baseline, 2-year
Scoliosis Research Society Quality of Life (SRS QOL) Subscore
Change was calculated as the SRS QOL Subscore value at 2-year as-treated follow-up minus the value at Baseline in the Observational cohort. SRS QOL Subscore value range is 1 to 5, where 5 is the best score and 1 is the worst score possible.
Baseline, 2-year
Secondary Outcomes (2)
Oswestry Disability Index (ODI) - Randomized Cohort
Baseline, 2-year
Oswestry Disability Index (ODI)
Baseline, 2-year
Study Arms (2)
Surgical Intervention
ACTIVE COMPARATORNon-Operative Intervention
ACTIVE COMPARATORInterventions
Surgical intervention as appropriate for adults with symptomatic lumbar scoliosis
Non operative intervention as appropriate for treatment of adults with symptomatic lumbar scoliosis such as: injections, medications, physical therapy, etc.
Eligibility Criteria
You may qualify if:
- aged 40 to 80 years with
- ASLS defined as lumbar curve with a coronal Cobb measurement ≥ 30°, and either of the following: Oswestry Disability Index (ODI) score ≥ 20 or SRS-QOL score ≤ 4.0 in the domains of pain, function and/or appearance.
- If assigned to surgical intervention (by randomization or patient preference), the intervention plan would include, at a minimum, the Cobb levels of the Thoracolumbar/lumbar spine.
You may not qualify if:
- Substantial cardiac, pulmonary, renal or metabolic disease that, in the judgment of the surgical team, would preclude performing an operative procedure without undue risk of morbidity and mortality
- Concomitant high-grade spondylolisthesis (Grade 3)
- Prior thoracic or lumbar fusion
- Osteoporosis evidence by a dual-energy x-ray absorptiometry (DEXA) T-score \<-3.0 at hip or lumbar spine for patients considered to be at risk (post menopausal females, males \> 60 years of age, steroid dependent rheumatoid arthritics, status post organ transplantation, etc.). Patients may be randomized prior to obtaining DEXA results. Non Surgical patients may initiate non surgical treatments prior to completion of DEXA (if required) as non surgical treatments will not affect DEXA results but DEXA must be completed and results entered within 3 months of enrollment. Surgical patient must have DEXA prior to surgical intervention.
- Neuromuscular scoliosis (e.g., spinal muscular atrophy, cerebral palsy, Parkinson's Disease, post-polio syndrome, Charcot Marie Tooth disease)
- Congenital scoliosis in the lumbar spine. Congenital anomalies of the cervical or thoracic spine are acceptable.
- Spine tumor, infection or connective tissue disorder
- Cognitively impaired or unable/unwilling to comply with follow-up
- Pregnancy or planning on conceiving during time of study involvement
- Ankylosing Spondylitis
- Past history of vertebroplasty or kyphoplasty of the thoracic or lumbar spine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Washington University School of Medicinelead
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)collaborator
- Northwestern Universitycollaborator
- New York Universitycollaborator
- University of Virginiacollaborator
- University of Louisvillecollaborator
- Maryland Spine Centercollaborator
- Hospital for Special Surgery, New Yorkcollaborator
- University Health Network, Torontocollaborator
- Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montrealcollaborator
- Dartmouth Collegecollaborator
Study Sites (9)
Northwestern University
Chicago, Illinois, 60611, United States
University of Louisville
Louisville, Kentucky, 40202, United States
Maryland Spine Center
Baltimore, Maryland, 21212, United States
Washington University
St Louis, Missouri, 63110, United States
New York University
New York, New York, 10010, United States
Hospital for Special Surgery
New York, New York, 10021, United States
University of Virginia
Charlottesville, Virginia, 22908, United States
Toronto Western Hospital
Toronto, Ontario, M5T 2S8, Canada
Hopital du Sacre'
Montreal, Quebec, HrJ 1C5, Canada
Related Publications (2)
Smith JS, Kelly MP, Yanik EL, Baldus CR, Pham V, Ben-Israel D, Lurie JD, Edwards C, Glassman SD, Lenke LG, Buchowski JM, Carreon LY, Crawford CH 3rd, Lewis SJ, Koski T, Lafage V, Gupta MC, Kim HJ, Ames CP, Bess S, Schwab FJ, Shaffrey CI, Bridwell KH. Operative vs Nonoperative Treatment for Adult Symptomatic Lumbar Scoliosis at 8-Year Follow-Up: A Nonrandomized Clinical Trial. JAMA Surg. 2025 Jun 1;160(6):634-644. doi: 10.1001/jamasurg.2025.0496.
PMID: 40172880DERIVEDDial BL, Hills JM, Smith JS, Sardi JP, Lazaro B, Shaffrey CI, Bess S, Schwab FJ, Lafage V, Lafage R, Kelly MP, Bridwell KH. The impact of lumbar alignment targets on mechanical complications after adult lumbar scoliosis surgery. Eur Spine J. 2022 Jun;31(6):1573-1582. doi: 10.1007/s00586-022-07200-3. Epub 2022 Apr 15.
PMID: 35428916DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Keith H. Bridwell, MD
- Organization
- Washington University
Study Officials
- PRINCIPAL INVESTIGATOR
Keith H Bridwell, MD
Washington University School of Medicine
- STUDY DIRECTOR
Jon Lurie, MD
Dartmouth-Hitchcock Medical Center
- STUDY DIRECTOR
Christopher Shaffrey, MD
University of Virginia
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2009
First Posted
March 3, 2009
Study Start
April 1, 2010
Primary Completion
February 28, 2017
Study Completion
February 28, 2017
Last Updated
September 14, 2021
Results First Posted
September 14, 2021
Record last verified: 2021-08